GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » CV Sciences Inc (OTCPK:CVSI) » Definitions » Cyclically Adjusted PS Ratio

CV Sciences (CV Sciences) Cyclically Adjusted PS Ratio : 0.27 (As of Jun. 07, 2024)


View and export this data going back to 2011. Start your Free Trial

What is CV Sciences Cyclically Adjusted PS Ratio?

As of today (2024-06-07), CV Sciences's current share price is $0.0887. CV Sciences's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2024 was $0.33. CV Sciences's Cyclically Adjusted PS Ratio for today is 0.27.

The historical rank and industry rank for CV Sciences's Cyclically Adjusted PS Ratio or its related term are showing as below:

CVSI' s Cyclically Adjusted PS Ratio Range Over the Past 10 Years
Min: 0.08   Med: 0.14   Max: 2.39
Current: 0.21

During the past years, CV Sciences's highest Cyclically Adjusted PS Ratio was 2.39. The lowest was 0.08. And the median was 0.14.

CVSI's Cyclically Adjusted PS Ratio is ranked better than
93.54% of 743 companies
in the Drug Manufacturers industry
Industry Median: 2.05 vs CVSI: 0.21

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

CV Sciences's adjusted revenue per share data for the three months ended in Mar. 2024 was $0.025. Add all the adjusted revenue per share for the past 10 years together and divide 10 will get our Cyclically Adjusted Revenue per Share, which is $0.33 for the trailing ten years ended in Mar. 2024.

Shiller PE for Stocks: The True Measure of Stock Valuation


CV Sciences Cyclically Adjusted PS Ratio Historical Data

The historical data trend for CV Sciences's Cyclically Adjusted PS Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

CV Sciences Cyclically Adjusted PS Ratio Chart

CV Sciences Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted PS Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only - 1.40 0.34 0.10 0.11

CV Sciences Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cyclically Adjusted PS Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.13 0.12 0.14 0.11 0.13

Competitive Comparison of CV Sciences's Cyclically Adjusted PS Ratio

For the Drug Manufacturers - Specialty & Generic subindustry, CV Sciences's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


CV Sciences's Cyclically Adjusted PS Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, CV Sciences's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where CV Sciences's Cyclically Adjusted PS Ratio falls into.



CV Sciences Cyclically Adjusted PS Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PS Ratio takes the Revenue per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/S calculation. Because it considers this 10-year average, it's often referred to as the CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio.

CV Sciences's Cyclically Adjusted PS Ratio for today is calculated as

Cyclically Adjusted PS Ratio=Share Price/ Cyclically Adjusted Revenue per Share
=0.0887/0.33
=0.27

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

CV Sciences's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2024 is calculated as:

For example, CV Sciences's adjusted Revenue per Share data for the three months ended in Mar. 2024 was:

Adj_RevenuePerShare=Revenue per Share/CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=0.025/131.7762*131.7762
=0.025

Current CPI (Mar. 2024) = 131.7762.

CV Sciences Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201406 0.090 100.560 0.118
201409 0.056 100.428 0.073
201412 0.081 99.070 0.108
201503 0.079 99.621 0.104
201506 0.069 100.684 0.090
201509 0.119 100.392 0.156
201512 0.062 99.792 0.082
201603 0.049 100.470 0.064
201606 0.048 101.688 0.062
201609 0.056 101.861 0.072
201612 0.057 101.863 0.074
201703 0.063 102.862 0.081
201706 0.049 103.349 0.062
201709 0.063 104.136 0.080
201712 0.080 104.011 0.101
201803 0.084 105.290 0.105
201806 0.110 106.317 0.136
201809 0.117 106.507 0.145
201812 0.113 105.998 0.140
201903 0.157 107.251 0.193
201906 0.139 108.070 0.169
201909 0.128 108.329 0.156
201912 0.094 108.420 0.114
202003 0.083 108.902 0.100
202006 0.054 108.767 0.065
202009 0.056 109.815 0.067
202012 0.052 109.897 0.062
202103 0.046 111.754 0.054
202106 0.048 114.631 0.055
202109 0.047 115.734 0.054
202112 0.045 117.630 0.050
202203 0.038 121.301 0.041
202206 0.031 125.017 0.033
202209 0.026 125.227 0.027
202212 0.026 125.222 0.027
202303 0.027 127.348 0.028
202306 0.026 128.729 0.027
202309 0.026 129.860 0.026
202312 0.024 129.419 0.024
202403 0.025 131.776 0.025

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


CV Sciences  (OTCPK:CVSI) Cyclically Adjusted PS Ratio Explanation

Compared with the regular PS Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PS Ratio smoothed out the fluctuations of revenue during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PS Ratio should give similar results to regular PS Ratio.


CV Sciences Cyclically Adjusted PS Ratio Related Terms

Thank you for viewing the detailed overview of CV Sciences's Cyclically Adjusted PS Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


CV Sciences (CV Sciences) Business Description

Traded in Other Exchanges
Address
9530 Padgett Street, Suite 107, San Diego, CA, USA, 92126
CV Sciences Inc is a consumer wellness company specializing in hemp extracts and other proven, science-backed, natural ingredients and products, which are sold through a range of sales channels from business-to-business (B2B) to business-to-consumer (B2C). The company also operates a drug development program focused on developing and commercializing cannabidiol (CBD)-based novel therapeutics.
Executives
William Mccorkle director 10070 BARNES CANYON ROAD, SAN DIEGO CA 92121
Corroon James Michael Jr. director 9530 PADGETT STREET, SUITE 107, SAN DIEGO CA 92126
Maroon Joseph C Md director 2688 S. RAINBOW BLVD., SUITE B, LAS VEGAS NV 89146
Mona Michael Joseph Jr director 2688 SOUTH RAINBOW BOULEVARD, SUITE B, LAS VEGAS NV 89146
Paul Blake director 145 BRANDYWINE PKWY, WEST CHESTER PA 19380
Douglas Jesse Mackay officer: Sr VP Scientific/Regulatory 10070 BARNES CANYON ROAD, SAN DIEGO CA 92121
Joseph D Dowling officer: Chief Financial Officer 2688 SOUTH RAINBOW BOULEVARD, SUITE B, LAS VEGAS NV 89146
Joerg Grasser officer: CFO 2688 SOUTH RAINBOW BLVD STE B, LAS VEGAS NV 89146
Elizabeth Ann Altman director 10070 BARNES CANYON ROAD, SAN DIEGO CA 92121
Terri F Graham director C/O JACK IN THE BOX INC, 9330 BALVOA AVE, SAN DIEGO CA 92123
Stephen Martin Schmitz director 2688 SOUTH RAINBOW BOULEVARD, SUITE B, LAS VEGAS NV 89146
Gary Sligar director 2688 SOUTH RAINBOW BOULEVARD, SUITE B, LAS VEGAS NV 89146
James A Mcnulty director C/O CV SCIENCES, INC., 2688 S. RAINBOW BLVD., SUITE B, LAS VEGAS NV 89146
Larry Phillip Raskin director 1630 FUNNY CIDE DRIVE, WAXHAW NC 28173
Mackay Ventures Inc. other: Member 10% holding group 6325 S. JONES BOULEVARD #500, LAS VEGAS NV 89118